Skip to main content

150 mg VISMO (Erivedge 150 mg)

Generic Name: vismodegib

Pill with imprint 150 mg VISMO is Pink / Gray, Capsule-shape and has been identified as Erivedge 150 mg. It is supplied by Genentech, Inc.

Erivedge is used in the treatment of basal cell carcinoma and belongs to the drug class hedgehog pathway inhibitors. There is positive evidence of human fetal risk during pregnancy. Erivedge 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 150 mg VISMO

Erivedge 150 mg 150 mg VISMO


Generic Name
150 mg VISMO
150 mg
Pink / Gray
Prescription only
Drug Class
Hedgehog pathway inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
Inactive Ingredients
microcrystalline cellulose, lactose monohydrate, sodium lauryl sulfate, povidone k30, sodium starch glycolate type A potato, magnesium silicate, magnesium stearate, titanium dioxide, ferric oxide red, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.